Combination Therapy for Chronic Hepatitis B: Current Updates and Perspectives

Tung-Hung Su ,  Chun-Jen Liu

Gut and Liver

2017 .01

Chronic Hepatitis C Virus Infection, Why Not Treat Now?

박경수

대한류마티스학회지

2018 .01

Changes in Hematological Parameters with Pegylated Interferon in Chronic Hepatitis C Virus Infected Patients

Rehman ,  Aziz U ,  Ali 외 9명

Asian Pacific journal of cancer prevention : APJCP

2016 .01

Toward a Functional Cure for Hepatitis B

Ray Gautam

Gut and Liver

2024 .07

Potential Efficacy of Pegylated Interferon-α and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B

Chung-Il Wi ,  W. Ray Kim ,  John B. G 외 5명

Gut and Liver

2016 .01

Healthcare Costs for Chronic Hepatitis C in South Korea from 2009 to 2013: An Analysis of the National Health Insurance Claims’ Data

기모란 ,  최화영 ,  김경아 외 2명

Gut and Liver

2017 .01

Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers

Lilian Yan Liang ,  Vincent Wai-Sun Wong ,  G 외 3명

Clinical and Molecular Hepatology

2023 .01

Association of Hepatitis B Virus Infection and Psoriasis

서현이 ,  윤용범 ,  안지영 외 2명

Annals of Dermatology

2017 .01

Long-term surgical outcomes of liver resection for hepatocellular carcinoma in patients with hepatitis B virus and hepatitis C virus co-infection: A multicenter observational study

Hang-Dong JIA ,  Lei LIANG ,  Chao LI 외 14명

Annals of Hepato-Biliary-Pancreatic Surgery

2021 .12

De novo hepatitis B virus infection after liver transplantation in hepatitis B core-positive recipients using hepatitis B core-negative grafts

Adianto Nug ,  oho ,  Kwang-Woong Lee 외 10명

한국간담췌외과학회 학술대회지

2015 .09

Simeprevir-Based Triple Therapy with Reduced Doses of Pegylated Interferon α-2a Plus Ribavirin for Interferon Ineligible Patients with Genotype 1b Hepatitis C Virus

Hideyuki Tamai ,  Yoshiyuki Ida ,  Aki 외 11명

Gut and Liver

2017 .07

Acute hepatitis A, B and C but not D is still prevalent in Mongolia: a time trend analysis

Oidov Baata ,  khuu ,  이혜원 외 14명

Clinical and Molecular Hepatology

2017 .06

Awareness and Access to Therapy in Hepatitis C Virus Infected Patients, Key Barriers to Eliminate the Virus?

Do Young Kim

Gut and Liver

2020 .01

Another oral antiviral treatment, but still far away from hepatitis B virus cure

Tai-Chung Tseng

Clinical and Molecular Hepatology

2021 .01

Acute pancreatitis associated with pegylated interferon-alpha-2a therapy in chronic hepatitis C

최종욱 ,  이준성 ,  백우현 외 5명

Clinical and Molecular Hepatology

2016 .01

The role of different viral biomarkers on the management of chronic hepatitis B

Lung-Yi Mak ,  Rex Wan-Hin Hui ,  James Fung 외 2명

Clinical and Molecular Hepatology

2023 .04

Survey on Hepatitis B virus and Hepatitis C Virus Coinfection in the Human Immunodeficiency Virus-infected Patients

Hye-Yeoun Lee ,  So-Hyun Lee ,  Woon-Ho Kim 외 4명

JOURNAL OF BACTERIOLOGY AND VIROLOGY

2022 .09

Barriers to treatment of failed or interferon ineligible patients in the era of DAA: single center study

서광일 ,  윤병철 ,  Weiquan James Li 외 3명

Clinical and Molecular Hepatology

2017 .01

Immunotherapy for Chronic Hepatitis B Virus Infection

Antonio Be ,  toletti ,  Nina Le Be 외 1명

Gut and Liver

2018 .01

Low-Dose Pegylated Interferon α-2b Plus Ribavirin for Elderly and/or Cirrhotic Patients with Genotype 2 Hepatitis C Virus

Hideyuki Tamai ,  Naoki Shingaki ,  Yoshiyuki Mo 외 14명

Gut and Liver

2016 .01